Study results with Senza HF Spinal Cord Stimulation System in pain published in Anesthesiology- Nevro Corp

Nevro Corp has announced the publication of the SENZA-RCT results with the Senza HF Spinal Cord Stimulation System in the Online edition of Anesthesiology. The SENZA-RCT pivotal study was a ground-breaking study that was the first to directly compare spinal cord stimulation (SCS) therapies for patients with chronic pain. The multicenter study compared the safety and effectiveness of HF10 therapy to traditional SCS therapy. The study enrolled 241 patients across 11 U.S. clinical trial sites (171 patients received SCS implants at 10 sites), making it the largest prospective randomized SCS study ever conducted to assess the treatment of chronic back and leg pain. The Senza SCS system received FDA approval in May of 2015.